Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 07 May 2021

Efficacy and Resistance of Afatinib in Chinese Non-Small Cell Lung Cancer Patients With HER2 Alterations: A Multicenter Retrospective Study

in Thoracic Oncology

Zhengbo Song
Dongqing Lv
Shiqing Chen
Jianhui Huang
Liping Wang
Shuguang Xu
Huafei Chen
Guoqiang Wang
Quan Lin

Frontiers in Oncology

doi 10.3389/fonc.2021.657283

5,130 views
16 citations

Original Research

Published on 07 May 2021

The Prognostic Value of Non-Predominant Micropapillary Pattern in a Large Cohort of Resected Invasive Lung Adenocarcinoma Measuring ≤3 cm

in Thoracic Oncology

Hua Zhang
Wuhao Huang
Chang Liu
Giuseppe Giaccone
Xiaoliang Zhao
Xiaoyan Sun
Jingjing Li
Runfen Cheng
Qiujuan Huang
Huilan Mo

Frontiers in Oncology

doi 10.3389/fonc.2021.657506

4,937 views
11 citations

Original Research

Published on 07 May 2021

Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching’s Study

in Thoracic Oncology

Bo Zhang
Renwang Liu
Dian Ren
Xiongfei Li
Yanye Wang
Huandong Huo
Shuai Zhu
Jun Chen
Zuoqing Song
Song Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.610638

4,863 views
23 citations

Original Research

Published on 06 May 2021

Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer

in Thoracic Oncology

Maria Gabriela O. Fernandes
Catarina Sousa
Maria Jacob
Leonor Almeida
Vanessa Santos
David Araújo
Hélder Novais Bastos
Adriana Magalhães
Luís Cirnes
Conceição Souto Moura

Frontiers in Oncology

doi 10.3389/fonc.2021.602924

4,336 views
5 citations

Original Research

Published on 04 May 2021

The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer

in Thoracic Oncology

Giuseppe Bronte
Maurizio Puccetti
Elisabetta Petracci
Lorenza Landi
Paola Cravero
Simona Scodes
Paola Ulivi
Sara Ravaioli
Maria Maddalena Tumedei
Marco Angelo Burgio

Frontiers in Oncology

doi 10.3389/fonc.2021.669839

2,884 views
6 citations

Review

Published on 04 May 2021

Combination of Immune Checkpoint Inhibitors and Anti-Angiogenic Agents in Brain Metastases From Non-Small Cell Lung Cancer

in Thoracic Oncology

Likui Fang
Wuchen Zhao
Bo Ye
Da Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.670313

4,600 views
19 citations

Review

Published on 03 May 2021

KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup

in Thoracic Oncology

Mingying Xie
Xiaoling Xu
Yun Fan

Frontiers in Oncology

doi 10.3389/fonc.2021.672612

25,266 views
68 citations

Original Research

Published on 30 Apr 2021

Integrating Histologic and Genomic Characteristics to Predict Tumor Mutation Burden of Early-Stage Non-Small-Cell Lung Cancer

in Thoracic Oncology

Yuan Qiu
Liping Liu
Haihong Yang
Hanzhang Chen
Qiuhua Deng
Dakai Xiao
Yongping Lin
Changbin Zhu
Weiwei Li
Di Shao

Frontiers in Oncology

doi 10.3389/fonc.2020.608989

6,524 views
17 citations

Original Research

Published on 29 Apr 2021

Radiomics-Based Features for Prediction of Histological Subtypes in Central Lung Cancer

in Thoracic Oncology

Huanhuan Li
Long Gao
He Ma
Dooman Arefan
Jiachuan He
Jiaqi Wang
Hu Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.658887

5,572 views
32 citations

Original Research

Published on 29 Apr 2021

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study

in Thoracic Oncology

Krittiya Korphaisarn
Pongwut Danchaivijitr
Thanyanan Reungwetwattana
Busayamas Chewaskulyong
Luangyot Thongthieang
Jarin Chindaprasirt
Kunlatida Maneenil
Chirawadee Sathitruangsak
Chanida Vinayanuwattikun

Frontiers in Oncology

doi 10.3389/fonc.2021.572740

3,799 views
6 citations

Systematic Review

Published on 29 Apr 2021

Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Xiaohan Qian
Mengjiao Fu
Jing Zheng
Jianya Zhou
Jianying Zhou

Frontiers in Oncology

doi 10.3389/fonc.2021.680191

4,750 views
20 citations

Original Research

Published on 28 Apr 2021

Identification of an Individualized Metabolism Prognostic Signature and Related Therapy Regimens in Early Stage Lung Adenocarcinoma

in Thoracic Oncology

Junjie Hu
Huansha Yu
Liangdong Sun
Yilv Yan
Lele Zhang
Gening Jiang
Peng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.650853

3,119 views
8 citations

Original Research

Published on 28 Apr 2021

Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation

in Thoracic Oncology

Rachelle Asciak
Nikolaos I. Kanellakis
Xuan Yao
Megat Abd Hamid
Rachel M. Mercer
Maged Hassan
Eihab O. Bedawi
Melissa Dobson
Peter Fsadni
Stephen Montefort

Frontiers in Oncology

doi 10.3389/fonc.2021.658395

4,352 views
17 citations

Original Research

Published on 27 Apr 2021

Characteristics of Ground-Glass Nodules Detected by Low-Dose Computed Tomography as a Regular Health Examination Among Chinese Hospital Employees and Their Parents

in Thoracic Oncology

Bihan Ouyang
Maoyuan Li
Li Li
Shaohui Liu
Min Li

Frontiers in Oncology

doi 10.3389/fonc.2021.661067

3,610 views
4 citations

Original Research

Published on 27 Apr 2021

Cost-Effectiveness Analysis of Atezolizumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer With Different PD-L1 Expression Status

in Thoracic Oncology

Guoqiang Liu
Shuo Kang
Xinchen Wang
Fangjian Shang

Frontiers in Oncology

doi 10.3389/fonc.2021.669195

7,012 views
28 citations

Original Research

Published on 27 Apr 2021

Comparison of Perioperative Outcomes Between Precise and Routine Segmentectomy for Patients With Early-Stage Lung Cancer Presenting as Ground-Glass Opacities: A Propensity Score-Matched Study

in Thoracic Oncology

Xianning Wu
Tian Li
Chuankai Zhang
Gao Wu
Ran Xiong
Meiqing Xu
Dan Su
Mingran Xie

Frontiers in Oncology

doi 10.3389/fonc.2021.661821

2,802 views
13 citations